Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
244 Leser
Artikel bewerten:
(1)

Global Peripheral Vascular Devices Market Size, Demands, Growth Rate, Share, Sales, Key Players, Devices Type and Forecasts to 2026 - ReportsnReports

PUNE, India, Sept. 30, 2022 /PRNewswire/ -- ReportsnReports added a Global Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices) and forecast to 2026 report to its online research database.

The global peripheral vascular devices market size is projected to reach USD 13.4 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favourable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption.

Download a Free Sample Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=181599

"Hemodynamic flow alteration devices in the product segment to witness the highest growth during the forecast period."

Based on the product, the peripheral vascular devices market is segmented into angioplasty balloon, angioplasty stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, other peripheral vascular devices. The Embolic Protection Devices segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this market are increasing investments in new technology development and the growing number of regulatory approvals for these devices, and venture capital funding for the development of advanced EPDs.

"Asia Pacific is estimated to register the highest CAGR during the forecast period."

In this report, the peripheral vascular devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising geriatric population, increasing awareness among surgeons about the benefits of minimally invasive surgeries, and the rising patient population base for target diseases in several APAC countries.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (32%), Tier 2(44%), and Tier 3 (24%)
  • By Designation: C-level (30%), Director-level (34%), and Others (36%)
  • By Region: North America (40%), Europe (28%), Asia Pacific (20%), and Rest of the World (12%)

Direct Purchase of the Global Peripheral Vascular Devices Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=181599

List of Companies Profiled in the Report

  • Medtronic (Ireland)
  • Boston Scientific Corporation (US)
  • Abbott (US)
  • Becton, Dickinson and Company (US)
  • Terumo Corporation (Japan)
  • Cardinal Health (US)
  • B. Braun Melsungen AG (US)
  • Merit Medical Systems (US)
  • Penumbra, Inc.(US)
  • Koninklijke Philips N.V ( Netherlands)
  • iVascular S.L.U (Spain)
  • Biosensors International Group Ltd. (Singapore)
  • BIOTRONIK (Germany)
  • AMG International GmbH (US)
  • ENDOCOR GmbH (Germany)
  • Meril Life Sciences Pvt. Ltd. (India)
  • Alvimedica (Turkey)
  • Cardionovum GMBH (Germany)
  • SMT (India)
  • Medinol Ltd. (Israel)
  • Andramed GMBH (Germany)
  • Cook (US)
  • Rex Medical (US)
  • Degania Silicone Ltd. (Israel)
  • BrosMed Medical (China)

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on peripheral vascular devices products offered by the top 25 players in the peripheral vascular devices market. The report analyzes the peripheral vascular devices market by product, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
  • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the peripheral vascular devices market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the peripheral vascular devices market.

Another Related Research Report:

Gastrointestinal Stent Market with COVID-19 Impact by Product (biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents), Material (self-expanding metal stents and plastic stents), Application, End User - Forecast to 2026 - The gastrointestinal stent market is expected to reach USD 600 million by 2026 from USD 457 million in 2021, at a CAGR of 5.6 % during the forecast period of 2021 to 2026. Purchase this report with available discount on website at https://www.reportsnreports.com/purchase.aspx?name=5409245

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:
Ganesh Pardeshi
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+1-888-391-5441
sales@reportsandreports.com

Connect With Us on:
Facebook:
https://www.facebook.com/ReportsnReports/
LinkedIn:
https://www.linkedin.com/company/reportsnreports
Twitter:
https://twitter.com/marketsreports

Cision View original content:https://www.prnewswire.co.uk/news-releases/global-peripheral-vascular-devices-market-size-demands-growth-rate-share-sales-key-players-devices-type-and-forecasts-to-2026---reportsnreports-301637655.html

© 2022 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.